Nanomedicine Market by Molecule Type (Nano Shells, Nanoparticles), Application (Active Implants, Therapeutics), Indication (Infectious diseases, Clinical Oncology), and by Region - Global Forecast to 2022-2033

The nanomedicine market size is estimated to be USD 161,287.1 million in 2022 and is expected to witness a CAGR of 11.97% during the forecast period 2023-2033. Expanding use of drug delivery techniques based on nanotechnology and the ineffectiveness of conventional treatments are some of the factors contributing to the market growth. Furthermore, increasing R&D expenditure and rising involvement of key market players are other factors supporting the market growth. However, lengthy approval process and risk related to nanomedicines is expected to hinder the growth.

Increasing R&D expenditure is expected to propel the market growth during the projected period. Government entities are expected to increase their R&D expenditure, creating enticing prospects for the growth of the nanomedicine market. Huge capital-intensive projects can be accelerated with the help of government funding. For instance, in order to enhance nanoscale engineering, science, and technology, the National Science Foundation announced in August 2020 that it will invest a total of $84 million over the course of five years in re-establishing the National Nanotechnology Coordinated Infrastructure.

Rising involvement of key market players is predicted to fuel the market growth during the forecast period. Manufacturers are profiting from enormous opportunities for expansion in the global market due to due to the rising demand for nanomedicines. Nanomedicine is expanding in the healthcare industry and is being used more frequently in clinical and healthcare settings. The development of this industry is also anticipated to be impacted by the renowned pharmaceutical companies’ active participation in the creation of cutting-edge medications based on nanoscience.

Segmentation

By Molecule Type

The market is categorized into nano shells, nanoparticles, nano devices, and nano tubes. In 2022, the nanoparticles segment accounted for the highest revenue share due to expanding use of metal and metal oxide particles in photodynamic therapy (PDT) for the treatment of cancer and infectious diseases and advantages of various nanoparticles. In the coming years, it is projected that the usage of nanoparticles in different health settings will encourage growth. These molecules’ ability to bind to chemical groups in the form of scaffolds allows them to perform a variety of functions. The use of nanoparticles for selective binding by adding them to ligands of cell receptors is one of the main methods used in nanotechnology. It will therefore spur market expansion.

By Application

The market is categorized into active implants, therapeutics, drug delivery, in-vitro diagnostics, in-vivo imaging, implants. In the global market, the therapeutics segment accounted for the largest revenue share in 2022 owing to wide range of products that belongs to this category for the treatment of different diseases. Drug delivery systems, equipment, and pharmaceuticals all are included in this category. The development of Nanotherapeutics that can penetrate biological barriers made possible by technological improvements is another factor that is projected to propel the nanomedicine market during the forecast period. The drug delivery market made a substantial contribution to the entire market in 2022 as increasing rates of diseases such as cancer and expanding public knowledge of the potential applications for nanomedicines.

By Indication

The market is segmented into infectious diseases, clinical oncology, orthopedics, clinical cardiology, others. In 2022, the clinical oncology segment accounted for the largest revenue share owing to rising prevalence of cancer diseases. The wide variety of cancer therapy products currently in the clinical phases of development and advancements in the introduction of theranostic particles and devices are related to the rising prevalence of cancer diseases. The technique can be applied as a tool for both active and passive cancer targeting, which will spur market expansion. Nanomedicine is a therapy method that is rapidly evolving due to its effectiveness in targeting and less side effects while treating cancer. The primary preclinical and clinical use of nanomedicine is to target a wide range of diseases and tumors.

Regional Markets

In 2022, North America region accounted for the highest revenue in the nanomedicine market and is expected to maintain its dominance during the forecast period. This is attributed to the increasing collaborations between established companies in this field and emerging nanomedicine start-ups. Additionally, the region’s substantial involvement in the industrial sector is attributable to rising R&D spending together with governmental support.  Surge in funding for research and increasing demand for life-threatening illness prophylaxis in the United States are factors fueling the market’s expansion. The country also has a substantial number of manufacturing companies engaged in strategic nanomedicine ventures. For instance, Advanced Nano Therapies raised $5.3 Million in Seed-Round Financing in October 2020 to accelerate the expansion of their drug delivery development platform that is centred on nanoparticles to treat peripheral artery disease and other various uses. The Asia Pacific area is anticipated to have the fastest CAGR over the forecast period due to rising public participation in consensus conferences related to nanoscience and nanotechnology. For instance, Beijing, China hosted the 9th International Conference on Nanoscience and Technology, China, in August 2022. (China NANO 2022).

Competitor Insights

Some of the key players operating in the nanomedicine market are Combi Matrix Corporation, Teva Pharmaceutical Industries Ltd., General Electric, Mallinckrodt Pharmaceuticals, Abbott Laboratories, Nano spectra Biosciences, Inc., Celgene Corporation, Johnson & Johnson Services, Inc., Pfizer, Inc., Merck & Co., Inc., and Arrowhead Pharmaceuticals, Inc.

To achieve a competitive edge, these companies are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

  • For instance, NaNotics LLC and Mayo Clinic announced their research partnership in January 2022 with the goal of developing a NaNot that selectively targets the soluble form of the immune inhibitor PD-L1, which is produced by tumors.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including molecule type, application, and indication from 2023 to 2033.

Report Scope:

Key Parameters Details
Market size in 2022
  • USD 161,287.1 Million
CAGR
  • 11.97%
Base Year
  • 2022
Forecast Period
  • 2023-2033
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • COVID-19 impact analysis
Segment Market Scope
  • Molecule Type
  • Application
  • Indication
Regional Market Scope
  • North America
    (U.S. and Canada)
  • Europe
    (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific
    (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America
    (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA
    (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 10 players
  • Other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Segmentation: Nanomedicine Market Report 2022 – 2033

Molecule Type (Revenue, USD Million), 2022 – 2033

  • Nano Shells
  • Nanoparticles
    • Inorganic Nanoparticles
    • Liposomes
    • Metal & Metal Oxide Nanoparticles
    • Hydrogel Nanoparticles
    • Polymers & Polymer Drug Conjugates
    • Dendrimers
  • Nano Devices
  • Nano Tubes

Application (Revenue, USD Million), 2022 – 2033

  • Active Implants
  • Therapeutics
  • Drug Delivery
  • In-vitro Diagnostics
  • In-vivo Imaging
  • Implants

Indication (Revenue, USD Million), 2022 – 2033

  • Infectious diseases
  • Clinical Oncology
  • Orthopedics
  • Clinical Cardiology
  • Others

By Region (Revenue, USD Million), 2022 – 2033

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Table of Contents: Nanomedicine Market 2022-2033

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
  1. Introduction: Nanomedicine
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. SWOT Analysis
  2. COVID-19 Impact Analysis: Nanomedicine Market
  3. Market Analysis by Molecule Type
    1. Nano Shells
      1. Nano Shells
    2. Nanoparticles
      1. Nanoparticles
        1. Inorganic Nanoparticles
          1. Inorganic NanoparticlesMarket Forecast, 2022-2033 (USD Million)
        2. Liposomes
          1. LiposomesMarket Forecast, 2022-2033 (USD Million)
        3. Metal & Metal Oxide Nanoparticles
          1. Metal & Metal Oxide NanoparticlesMarket Forecast, 2022-2033 (USD Million)
        4. Hydrogel Nanoparticles
          1. Hydrogel NanoparticlesMarket Forecast, 2022-2033 (USD Million)
        5. Polymers & Polymer Drug Conjugates
          1. Polymers & Polymer Drug ConjugatesMarket Forecast, 2022-2033 (USD Million)
        6. Dendrimers
          1. DendrimersMarket Forecast, 2022-2033 (USD Million)
        7. Nano Devices
          1. Nano Devices Market Forecast, 2022-2033(USD Million)
        8. Nano Tubes
          1. Nano Tubes Market Forecast, 2022-2033(USD Million)
  1. Market Analysis by Application
    1. Active Implants
      1. Active Implants Market Forecast, 2022-2033(USD Million)
    2. Therapeutics
      1. Therapeutics Market Forecast, 2022-2033(USD Million)
    3. Drug Delivery
      1. Drug Delivery Market Forecast, 2022-2033(USD Million)
    4. In-vitro Diagnostics
      1. In-vitro Diagnostics Market Forecast, 2022-2033(USD Million)
    5. In-vivo Imaging
      1. In-vivo Imaging Market Forecast, 2022-2033(USD Million)
    6. Implants
      1. Implants Market Forecast, 2022-2033(USD Million)
  1. Market Analysis by Indication
    1. Infectious diseases
      1. Infectious diseases Market Forecast, 2022-2033(USD Million)
    2. Clinical Oncology
      1. Clinical Oncology Market Forecast, 2022-2033(USD Million)
    3. Orthopedics
      1. Orthopedics Market Forecast, 2022-2033(USD Million)
    4. Clinical Cardiology
      1. Clinical Cardiology Market Forecast, 2022-2033(USD Million)
    5. Others
      1. OthersMarket Forecast, 2022-2033 (USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends Analysis
  2. North America Nanomedicine Market
    1. North America Nanomedicine Market
      1. North America Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Molecule Type, 2022-2033(USD Million)
        2. Market Size and Forecast by Application, 2022-2033(USD Million)
        3. Market Size and Forecast by Indication, 2022-2033(USD Million)
      2. S. Nanomedicine Market
        1. S. Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Molecule Type, 2022-2033(USD Million)
          2. Market Size and Forecast by Application, 2022-2033(USD Million)
          3. Market Size and Forecast by Indication, 2022-2033(USD Million)
        2. Canada Nanomedicine Market
          1. Canada Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Molecule Type, 2022-2033(USD Million)
            2. Market Size and Forecast by Application, 2022-2033(USD Million)
            3. Market Size and Forecast by Indication, 2022-2033(USD Million)
  1. Europe Nanomedicine Market
    1. Europe Nanomedicine Market
      1. Europe Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Molecule Type, 2022-2033(USD Million)
        2. Market Size and Forecast by Application, 2022-2033(USD Million)
        3. Market Size and Forecast by Indication, 2022-2033(USD Million)
      2. Germany Nanomedicine Market
        1. Germany Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Molecule Type, 2022-2033(USD Million)
          2. Market Size and Forecast by Application, 2022-2033(USD Million)
          3. Market Size and Forecast by Indication, 2022-2033(USD Million)
        2. UK Nanomedicine Market
          1. UK Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Molecule Type, 2022-2033(USD Million)
            2. Market Size and Forecast by Application, 2022-2033(USD Million)
            3. Market Size and Forecast by Indication, 2022-2033(USD Million)
          2. France Nanomedicine Market
            1. France Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Molecule Type, 2022-2033(USD Million)
              2. Market Size and Forecast by Application, 2022-2033(USD Million)
              3. Market Size and Forecast by Indication, 2022-2033(USD Million)
            2. Spain Nanomedicine Market
              1. Spain Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Molecule Type, 2022-2033(USD Million)
                2. Market Size and Forecast by Application, 2022-2033(USD Million)
                3. Market Size and Forecast by Indication, 2022-2033(USD Million)
              2. Italy Nanomedicine Market
                1. Italy Market Size and Forecast, 2022-2033(USD Million)
                  1. Market Size and Forecast by Molecule Type, 2022-2033(USD Million)
                  2. Market Size and Forecast by Application, 2022-2033(USD Million)
                  3. Market Size and Forecast by Indication, 2022-2033(USD Million)
                2. Rest of Europe Nanomedicine Market
                  1. Rest of Europe Market Size and Forecast, 2022-2033(USD Million)
                    1. Market Size and Forecast by Molecule Type, 2022-2033(USD Million)
                    2. Market Size and Forecast by Application, 2022-2033(USD Million)
                    3. Market Size and Forecast by Indication, 2022-2033(USD Million)
  1. Asia Pacific Nanomedicine Market
    1. Asia Pacific Nanomedicine Market
      1. Asia Pacific Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Molecule Type, 2022-2033(USD Million)
        2. Market Size and Forecast by Application, 2022-2033(USD Million)
        3. Market Size and Forecast by Indication, 2022-2033(USD Million)
      2. Japan Nanomedicine Market
        1. Japan Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Molecule Type, 2022-2033(USD Million)
          2. Market Size and Forecast by Application, 2022-2033(USD Million)
          3. Market Size and Forecast by Indication, 2022-2033(USD Million)
        2. China Nanomedicine Market
          1. China Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Molecule Type, 2022-2033(USD Million)
            2. Market Size and Forecast by Application, 2022-2033(USD Million)
            3. Market Size and Forecast by Indication, 2022-2033(USD Million)
          2. India Nanomedicine Market
            1. India Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Molecule Type, 2022-2033(USD Million)
              2. Market Size and Forecast by Application, 2022-2033(USD Million)
              3. Market Size and Forecast by Indication, 2022-2033(USD Million)
            2. South Korea Nanomedicine Market
              1. South Korea Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Molecule Type, 2022-2033(USD Million)
                2. Market Size and Forecast by Application, 2022-2033(USD Million)
                3. Market Size and Forecast by Indication, 2022-2033(USD Million)
              2. Australia Nanomedicine Market
                1. Australia Market Size and Forecast, 2022-2033(USD Million)
                  1. Market Size and Forecast by Molecule Type, 2022-2033(USD Million)
                  2. Market Size and Forecast by Application, 2022-2033(USD Million)
                  3. Market Size and Forecast by Indication, 2022-2033(USD Million)
                2. Rest of Asia Pacific Nanomedicine Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2022-2033(USD Million)
                    1. Market Size and Forecast by Molecule Type, 2022-2033(USD Million)
                    2. Market Size and Forecast by Application, 2022-2033(USD Million)
                    3. Market Size and Forecast by Indication, 2022-2033(USD Million)
  1. Latin America Nanomedicine Market
    1. Latin America Nanomedicine Market
      1. Latin America Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Molecule Type, 2022-2033(USD Million)
        2. Market Size and Forecast by Application, 2022-2033(USD Million)
        3. Market Size and Forecast by Indication, 2022-2033(USD Million)
      2. Brazil Nanomedicine Market
        1. Brazil Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Molecule Type, 2022-2033(USD Million)
          2. Market Size and Forecast by Application, 2022-2033(USD Million)
          3. Market Size and Forecast by Indication, 2022-2033(USD Million)
        2. Mexico Nanomedicine Market
          1. Mexico Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Molecule Type, 2022-2033(USD Million)
            2. Market Size and Forecast by Application, 2022-2033(USD Million)
            3. Market Size and Forecast by Indication, 2022-2033(USD Million)
          2. Argentina Nanomedicine Market
            1. Argentina Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Molecule Type, 2022-2033(USD Million)
              2. Market Size and Forecast by Application, 2022-2033(USD Million)
              3. Market Size and Forecast by Indication, 2022-2033(USD Million)
            2. Rest of Latin America Nanomedicine Market
              1. Rest of Latin America Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Molecule Type, 2022-2033(USD Million)
                2. Market Size and Forecast by Application, 2022-2033(USD Million)
                3. Market Size and Forecast by Indication, 2022-2033(USD Million)
  1. MEA Nanomedicine Market
    1. MEA Nanomedicine Market
      1. MEA Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Molecule Type, 2022-2033(USD Million)
        2. Market Size and Forecast by Application, 2022-2033(USD Million)
        3. Market Size and Forecast by Indication, 2022-2033(USD Million)
      2. GCC Nanomedicine Market
        1. GCC Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Molecule Type, 2022-2033(USD Million)
          2. Market Size and Forecast by Application, 2022-2033(USD Million)
          3. Market Size and Forecast by Indication, 2022-2033(USD Million)
        2. South Africa Nanomedicine Market
          1. South Africa Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Molecule Type, 2022-2033(USD Million)
            2. Market Size and Forecast by Application, 2022-2033(USD Million)
            3. Market Size and Forecast by Indication, 2022-2033(USD Million)
          2. Rest of MEA Nanomedicine Market
            1. Rest of MEA Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Molecule Type, 2022-2033(USD Million)
              2. Market Size and Forecast by Application, 2022-2033(USD Million)
              3. Market Size and Forecast by Indication, 2022-2033(USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2022
    2. Major Recent Developments, 2019-2022
  2. Company Profiles
    1. Combi Matrix Corporation
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    2. Teva Pharmaceutical Industries Ltd.
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    3. General Electric
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    4. Mallinckrodt Pharmaceuticals
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    5. Abbott Laboratories
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    6. Nano spectra Biosciences, Inc.
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    7. Celgene Corporation
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    8. Johnson & Johnson Services, Inc
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    9. Pfizer, Inc.
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    10. Merck & Co., Inc.
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    11. Arrowhead Pharmaceuticals, Inc.
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    12. Company 12
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    13. Company 13
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    14. Company 14
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
  1. Conclusion
  2. Recommendations

Leave a comment

Your email address will not be published. Required fields are marked *

Select License Type

5 reasons to choose Quintana Research Reports

Our top-quality, real-time, accurate, and data-driven research aims at empowering the clients with actionable insights.

We deliver timely data-driven insights to help clients make informed decisions and achieve growth and success.

Our team of experts is available 24*7 to offer incisive analysis of the market for clients.

We offer comprehensive and bespoke marketing research as per clients’ requirements.

Our cost-effective and rapid research helps clients gain competitive intelligence, and uncover potential opportunities & threats.